CIK: 0001281446 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 14, 2019
Total Value ($000): $900,806,000 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | 5,260,803 | $128,995,000 | 14.3% | $9.91 | +52.0% | COM | 462260100 |
| PTCT | PTC THERAPEUTICS, INC. | 1,974,385 | $88,847,000 | 9.9% | $28.46 | +38.7% | COM | 69366J200 |
| — | ZOGENIX, INC. | 1,593,396 | $76,132,000 | 8.5% | $11839.82 | — | COM | 98978L204 |
| — | AUDENTES THERAPEUTICS, INC. | 1,922,937 | $72,802,000 | 8.1% | $6914.70 | — | COM | 05070R104 |
| KURA | KURA ONCOLOGY, INC. | 3,047,800 | $60,011,000 | 6.7% | $12.67 | +31.0% | COM | 50127T109 |
| — | ACCELERON PHARMA INC | 1,449,300 | $59,537,000 | 6.6% | $18289.17 | — | COM | 00434H108 |
| ASND | ASCENDIS PHARMA AS | 500,000 | $57,575,000 | 6.4% | $19673.19 | — | SPOSORED ADR | 04351P101 |
| — | TRICIDA, INC. | 1,423,998 | $56,191,000 | 6.2% | $39460.03 | — | COM | 89610F101 |
| ACAD | ACADIA PHARMACEUTICALS, INC. | 1,500,000 | $40,095,000 | 4.5% | $18.73 | +36.4% | COM | 004225108 |
| — | MIRATI THERAPEUTICS INC. | 300,000 | $30,900,000 | 3.4% | $103000.00 | — | Put | 60468T105 |
| — | MIRATI THERAPEUTICS INC. | 300,000 | $30,900,000 | 3.4% | $103000.00 | — | COM | 60468T105 |
| — | ZYMEWORKS INC. | 1,064,041 | $23,409,000 | 2.6% | $21698.24 | — | COM | 98985W102 |
| — | RETROPHIN INC. | 1,003,600 | $20,162,000 | 2.2% | $20089.68 | — | COM | 761299106 |
| — | MIRATII THERAPEUTICS INC. | 175,000 | $18,025,000 | 2.0% | $103000.00 | — | Call | 60468T105 |
| PRTA | PROTHENA CORPORATION PLC | 1,676,250 | $17,718,000 | 2.0% | $10.27 | 0.0% | COM | G72800108 |
| — | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. | 350,000 | $15,327,000 | 1.7% | $43791.43 | — | COM | G11196105 |
| — | MILLENDO THERAPEUTICS, INC. | 1,288,093 | $14,891,000 | 1.7% | $7.95 | — | COM | 60040X103 |
| — | DERMIRA INC. | 1,552,900 | $14,846,000 | 1.6% | $338.76 | — | COM | 24983L104 |
| — | ZOGENIX, INC. | 300,000 | $14,334,000 | 1.6% | $11839.82 | — | Put | 98978L204 |
| GNFTY | GENFIT | 694,253 | $13,711,000 | 1.5% | $24.00 | — | ADS | 372279109 |
| — | MENLO THERAPEUTICS INC. | 1,733,882 | $10,386,000 | 1.2% | $7.51 | — | COM | 586858102 |
| — | BIOHAVEN PHARMACEUTICAL HOLDING CO. LTD. | 200,000 | $8,758,000 | 1.0% | $43791.43 | — | Put | G11196105 |
| — | FOAMIX PHARMACEUTICALS LTD | 2,110,071 | $5,022,000 | 0.6% | $7.50 | — | COM | M46135105 |
| IOVA | IOVANCE BIOTHERAPETUICS, INC. | 200,000 | $4,904,000 | 0.5% | $9.91 | +52.0% | Call | 462260100 |
| — | MOMENTA PHARMACEUTICALS, INC. | 342,064 | $4,259,000 | 0.5% | $1196.13 | — | COM | 60877T100 |
| RVLPQ | OSMOTICA PHARMACEUTICALS PLC | 926,933 | $3,522,000 | 0.4% | $8.00 | -58.5% | COM | G6S41R101 |
| — | PROTEOSTASIS THERAPEUTICS INC. | 3,500,000 | $3,416,000 | 0.4% | $2.98 | — | COM | 74373B109 |
| — | FIVE PRIME THERAPEUTICS, INC. | 547,712 | $3,303,000 | 0.4% | $6226.03 | — | COM | 33830X104 |
| — | ZAFGEN INC. | 2,211,194 | $2,631,000 | 0.3% | $9.93 | — | COM | 98885E103 |
| — | STREAMLINE HEALTH SOLUTNS, INC. | 130,137 | $197,000 | 0.0% | $6.45 | — | COM | 86323X106 |